Historical record - last NADAC effective date: 7/1/2024
Product Information
LICART 1.3% PATCH is a brand product labeled by IBSA Pharma Inc., priced at $24.7113 per EA under NDC 71858030505. Its NADAC has been published 68 times since Jun 21, 2023.
FDA first approved this application on Dec 19, 2018.
Strength
.013 g/1
Manufacturer
IBSA Pharma Inc.NDC
71858030505
Classification
Brand
Dosage Form
SYSTEM
Route
TOPICAL
Effective Date
7/1/2024
Active Ingredients
DICLOFENAC EPOLAMINEApproval Type
New Drug (NDA)
FDA Application
NDA206976FDA Approved
12/19/2018
On Market Since
9/1/2020
Pharmacological Classes
Price Statistics
The NADAC for LICART 1.3% PATCH has been published 68 times since Jun 21, 2023, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.7113 per EA |
|---|---|
| All-time high | $24.7113 (Oct 2, 2024) |
| All-time low | $23.8581 (Jun 21, 2023) |
| Median price | $23.9879 |
| Average price | $24.1579 |
| Largest weekly change | +2.7% (Jun 26, 2024) |
| Weeks tracked | 68 |
| Tracking since | Jun 21, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.0%
5Y
N/A
All
+3.6%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LICART 1.3% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LICART 1.3% PATCH, manufactured by IBSA Pharma Inc., is $24.7113 per EA (NDC 71858030505), effective Oct 2, 2024.
How has the price of LICART 1.3% PATCH changed over time?
Over the history we have for it, the NADAC for LICART 1.3% PATCH has risen 3.6%. It has been tracked across 68 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for LICART 1.3% PATCH?
Since Jun 21, 2023, the NADAC for LICART 1.3% PATCH has ranged from a low of $23.8581 (Jun 21, 2023) to a high of $24.7113 (Oct 2, 2024), with a median of $23.9879 per EA.
Are there cheaper alternatives to LICART 1.3% PATCH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC EPOLAMINE 1.3% PTCH, is $4.8100 per EA — about 81% below LICART 1.3% PATCH.
Who manufactures LICART 1.3% PATCH?
LICART 1.3% PATCH (NDC 71858030505) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.